Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Europe’s more stringent medtech review may bring costly delays
The European Commission’s updated medtech review guidelines, expected to drop this month, may take some cues from the FDA in bolstering regulatory oversight – and potentially delaying market access.
2. Devices vs. drugs: New research puts pressure on stent makers, may hinder Medicare coverage
New research sheds doubt on the benefits of stent-based stroke prevention, putting pressure on carotid device makers such as Boston Scientific, Abbott, and Johnson & Johnson.
1. Medical device tax: Sen. Hagan says Congress should work on repeal
Members of Congress should work together to find a financially responsible way to repeal the medical device tax, Sen. Kay Hagan tells the North Carolina Chamber of Commerce.
